High response rates with new treatments for advanced ovarian cancer Lawrence Prescott Newsletter Article 03 February 2013 Pages: 3 - 4
Switch from oral to depot antipsychotic use and save Newsletter Article 03 February 2013 Pages: 6 - 6
Cost effectiveness of osteoporosis therapies compared Newsletter Article 03 February 2013 Pages: 6 - 6
Anti-E-selectin antibody shows promise in septic shock Newsletter Article 03 February 2013 Pages: 8 - 8
AG-490: cancer cell apoptosis in lymphoblastic leukaemia Newsletter Article 03 February 2013 Pages: 8 - 8
Rough road to development for neuroprotectants in acute stroke Robert H Carlson Newsletter Article 03 February 2013 Pages: 9 - 10
Magnesium repletion corrects hypokalaemia in the critically ill Newsletter Article 03 February 2013 Pages: 11 - 11
Atovaquone + proguanil: almost 100% cure rate in malaria Newsletter Article 03 February 2013 Pages: 12 - 12
Longer gonadorelin agonist therapy preferred in assisted reproduction Newsletter Article 03 February 2013 Pages: 12 - 12
Benefit of selegiline not sustained in Parkinson’s disease Newsletter Article 03 February 2013 Pages: 14 - 14
Looking at topical β-blocker prescriptions for glaucoma Newsletter Article 03 February 2013 Pages: 14 - 14
Carbamazepine beats combativeness after traumatic brain injury Newsletter Article 03 February 2013 Pages: 16 - 16
Enalapril well tolerated in most patients with LVD Newsletter Article 03 February 2013 Pages: 19 - 19
Thioacetazone: cutaneous ADRs increased in HIV infection Newsletter Article 03 February 2013 Pages: 19 - 19
Spotlight on CIOMS & its role in harmonising ADR reporting Robert Short Newsletter Article 03 February 2013 Pages: 20 - 21